Meeting people where they are: implementing hospital-based substance use harm reduction
Harm Reduction Journal volume 19, Article number: 14 (2022)
Hospital-based addiction care focuses on assessing and diagnosing substance use disorders, managing withdrawal, and initiating medications for addiction treatment. Hospital harm reduction is generally limited to prescribing naloxone. Hospitals can better serve individuals with substance use disorders by incorporating harm reduction education and equipment provision as essential addiction care. We describe the implementation of a hospital intervention that provides harm reduction education and equipment (e.g., syringes, pipes, and fentanyl test strips) to patients via an addiction consult team in an urban, safety-net hospital.
We performed a needs assessment to determine patient harm reduction needs. We partnered with a community-based organization who provided us harm reduction equipment and training. We engaged executive, regulatory, and nursing leadership to obtain support. After ensuring regulatory compliance, training our team, and developing a workflow, we implemented this harm reduction program that provides education and equipment to individuals whose substance use goals do not include abstinence.
During a 12-month period we provided 195 individuals harm reduction kits.
This intervention allowed us to advance hospital-based addiction care, better educate and engage patients, staff, and clinicians, and reduce stigma. By establishing a community harm reduction partner, obtaining support from hospital leadership, and incorporating feedback from staff, clinicians, and patients, we successfully implemented harm reduction education and equipment provision in a hospital setting as part of evidence-based addiction care.
Trial registration: Commentary, none.
Unhealthy substance use and substance-related deaths are rising at astounding rates. In the 12-month period ending May 2021, over 100,000 individuals in the US died of drug-related overdoses . Substance use disorder (SUD)-related emergency department visits and hospitalizations have simultaneously increased .
Hospitalized patients with SUD have longer lengths of stay and higher self-discharge and readmission rates than those without SUD, often related to inadequately treated withdrawal, pain, and stigma [3, 4]. Hospital-based addiction care is focused on diagnosing SUD, treating withdrawal, initiating medications for SUD, and prescribing naloxone for overdose reversal [5, 6]. However, these interventions alone fail to meet the needs of individuals who will continue to use substances.
Hospitals can better serve patients with SUD by more fully integrating harm reduction. We describe the implementation of harm reduction education and equipment provision (e.g., syringes, pipes, fentanyl test strips, and other safe use supplies) in an urban, safety-net hospital. To our knowledge, this is the first published guideline of how to integrate harm reduction education and equipment distribution in a US hospital as part of evidence-based addiction care.
The National Harm Reduction Coalition defines harm reduction as “a set of practical strategies and ideas aimed at reducing negative consequences associated with drug use” . Harm reduction recognizes that harms from substance use are real and that people use substances for complex reasons including racism, poverty, trauma, pain, homelessness, and gender-based violence . Harm reduction can be practiced across substances and route of use. Examples of harm reduction include supervised consumption sites, managed alcohol programs, sobering centers, safe supply, and syringe service programs (SSPs).
Our hospital-based harm reduction intervention focused on education and equipment provision given patient needs and legalities. As our intervention is most similar to SSPs, we briefly review their history and evidence. People who use drugs opened the first SSP in Rotterdam in 1985 in an effort to reduce hepatitis B infections . People who use drugs continued spearheading SSPs throughout the 1980s given newfound awareness of the prevalence of HIV among people who inject drugs . Today, SSPs distribute substance use equipment and often provide supportive services including hepatitis C and HIV testing and treatment, overdose prevention, naloxone, condoms, and addiction service referrals. SSP interventions reduce viral and bacterial infections and increase SUD treatment engagement [9, 10]. Moreover, people who engage in SSPs are five times likelier to enter addiction treatment and three times likelier to abstain from substances that those who do not .
As of August 2019, 31 US states and the District of Columbia have authorized SSPs, though regulations vary geographically . In California, where we are based, Health and Safety Code 11364.7(a) allows for distribution of syringes and other materials deemed by the local or state health department to prevent infection transmission, drug overdose, injury, and disability by a public entity, its agents, and employees through a certified SSP . It is unclear whether healthcare sites are considered SSP extensions as a “public entity.” In addition, the same safety code criminalizes possession of safer use supplies––except for needles obtained through SSPs.
Given complex regulations and legal concerns, most US healthcare settings have not implemented harm reduction equipment provision. However, in Canada, where regulations are different, evidence shows hospital-based harm reduction interventions improve patient–clinician experiences, reduce stigma, reach populations missed by traditional interventions, and advance health knowledge [14,15,16].
Harm reduction implementation
The Addiction Care Team (ACT) is an interprofessional consultation service composed of patient navigators, licensed vocational nurses, and clinicians that provide addiction services to emergency department and hospitalized patients in an urban, safety-net hospital . We tailor care to patients’ circumstances and goals with a focus on evidence-based addiction treatment, harm reduction, and linkage to community services.
With the aims of (1) integrating harm reduction as an evidence-based SUD service; (2) engaging patients in SUD care regardless of their stage of change; and (3) reducing stigma toward people with SUD, ACT implemented harm reduction education and equipment provision during hospitalization.
Identifying harm reduction need and a community partner
In May 2020, ACT navigators assessed the harm reduction needs of 30 hospitalized patients whose substance use goal was not abstinence. Patients identified the harm reduction supplies that could help them use substances more safely and whether they wanted to receive supplies at hospital discharge.
Our team also contacted the San Francisco AIDS Foundation, a community-based organization that serves people who use drugs and people living with HIV. The organization agreed to supply harm reduction equipment. The needs assessment and San Francisco AIDS Foundation education allowed our team to center lived-experience in local substance use practices, supply trends, and harm reduction strategies, which served as the basis for our intervention.
Obtaining executive and nursing leadership support
We contacted the hospital’s executive leadership (CEO, CMO, CNO) and the Director of Regulatory Affairs and described our goals and needs assessment results, which demonstrated patient need for harm reduction supplies at discharge. After confirming that a community partner would provide harm reduction equipment and establishing a process for documentation, leadership approved this intervention. This process was straightforward since we were not purchasing harm reduction equipment.
Our team also met with nursing leadership. Engaging nurses was critical given their patient facing role and likelihood of observing harm reduction equipment distribution. Nurses expressed concerns about the workflow, regulations, safety, and in-hospital substance use. To address these, we obtained nursing input in operationalization, reviewed harm reduction evidence, and acknowledged the strain that substance use can have on patient, staff, and clinician relationships. We also discussed how harm reduction could alleviate friction, foster alliance, increase treatment engagement, and reduce stigma [14, 17].
Operationalizing a workflow
ACT members attended trainings on harm reduction principles, safer injection practices, and overdose prevention . One navigator had worked at a SSP and reviewed substance use equipment with our team. Another navigator compiled harm reduction resources into a shared directory. Our community partner also recorded a peer navigator led harm reduction equipment training that we use to onboard new members.
We assemble harm reduction kits by substance and route of use to streamline distribution, and adjust each kit based on individual patient needs. All kits include information about community harm reduction programs, mental health services, and overdose prevention. See Table 1 for harm reduction kit components by substance and route of use, and rationale.
We developed harm reduction hospital workflow with patient, staff, and clinician feedback. We give kits at discharge to reduce the risk of misunderstandings between staff, clinicians, and patients. We inform the patient’s care team when we give a harm reduction kit and invite them to participate in education. Our documentation includes the equipment provided, as recommended by our hospital’s regulatory department.
Piloting harm reduction education and kits
In August 2020, we piloted our intervention on two medical-surgical floors to test and adjust the workflow. During this time, staff and clinicians alerted our team that many remained unaware of this intervention, highlighting the need for education. We also missed distributing kits to patients discharged when ACT members were unavailable. Thus, we updated our workflow to review kits with patients upon consult and store them in a locked cabinet in the patient room to be opened by nurses at discharge rather than attempting discharge delivery. This reduced the number of patients who did not receive a kit and allowed access regardless of ACT presence at discharge. In January 2021, after revising our workflow based on the pilot, we expanded it hospital wide.
From August 2020 to July 2021, we provided 195 harm reduction kits. As we focused on implementation, we did not collect detailed data. However, among 57 individuals served by this intervention we found that kits were given across substances (opioid, alcohol, cocaine, methamphetamine, benzodiazepine, tobacco, and cannabis), race/ethnicity (Latinx 29.9%, white 28.1%, Black 26.3%, Asian 8.8%, other 6.9%), and housing status (experiencing homelessness 38.6%, marginal housing 28.1%, housed 31.6%, unknown 1.7%).
We successfully implemented this intervention by assessing the harm reduction needs of patients with SUD, community partnership, obtaining hospital, regulatory, and nursing leadership support, training staff, and developing a workflow. This intervention educated and engaged patients, staff, and clinicians and reduced stigma.
Education and engagement
Patients, staff, and clinicians reported being unaware of infection risks associated with smoking and inhaling substances and reusing or sharing cookers. They were also unaware that stimulants warrant overdose prevention and that harm reduction for stimulants includes naloxone, fentanyl test strips for cocaine, test doses, and a 24-h overdose prevention hotline if using substances alone. Clinicians began consulting ACT for harm reduction support after this intervention launched, suggesting increased harm reduction awareness.
Patients new to San Francisco reported reusing and sharing equipment. They were relieved to receive equipment and learn about local harm reduction programs during hospitalization. Patients who smoked or inhaled substances appreciated learning that SSPs offer pipes, pipe covers, and fentanyl test strips. Those with limited English proficiency were generally unaware of naloxone. Patients with limited mobility and those discharging to a location without harm reduction programs were thankful for discharge access to harm reduction kits.
Patients who initially did not want ACT services became interested upon learning we offered harm reduction equipment. Patients commented that our harm reduction services allowed for more open discuss about substance use goals. Multiple patients contacted us when they were discharging before their expected date to ensure they received a harm reduction kit.
Patients, staff, and clinicians reported that this intervention reduced addiction-related stigma. Staff and clinicians expressed legality concerns and worried providing harm reduction equipment led to increased substance use. Some nurses expressed discomfort when asked to give harm reduction supplies at discharge. We approach these moments as opportunities to describe harm reduction evidence, reflect on how we can improve addiction care, and discuss the role of stigma.
Many patients shared previous experiences of discrimination, which had delayed and prevented healthcare engagement. Several patients contrasted those instances to their current hospitalization. They expressed relief about discussing substance use and their needs and goals without judgment during hospitalization. Patients endorsed excitement about improving personal well-being and the well-being of loved ones with harm reduction. Only one patient expressed that offering needles made him feel triggered to use drugs.
Currently, our intervention relies on ACT seeing a patient. Since ACT demand exceeds capacity, we must increase access to harm reduction education and equipment regardless of ACT availability. While we aim to educate staff and clinicians, we are limited by clinical demands, and there is a need for more systems-wide addiction education to staff and clinicians.
Incorporating harm reduction in healthcare systems meets people with SUD where they are and is an essential evidence-base addiction service. This intervention allowed us to advance evidence-based care for people with SUD, better educate and engage patients, staff, and clinicians, and reduce stigma.
Our findings are limited given informal feedback from patients, staff, and clinicians. We plan to evaluate how this intervention affected patient outcomes and patient, staff, and clinician experiences. We need formal studies to build evidence for hospital-based harm reduction interventions so that they can be implemented more widely in the US.
While our hospital-based harm reduction education and equipment provision intervention is promising, we recognize that we must continue advancing addiction interventions. In hospital settings, this means expanding access to evidence-based addiction services. Further work to implement and evaluate more expansive harm reduction interventions, including supervised consumption sites and safe supply, is also necessary. Simultaneously, we must also address the factors that interplay with addiction including trauma, mental health, and housing access, and ensure equitable and low-threshold access to evidence-based addiction services for minoritized communities and those with limited English proficiency, who often face reduced access to treatment and worse addiction-related outcomes.
Harm reduction in hospitals is a critical component of evidence-based addiction care and includes, educates, and empowers patients. This guideline can help US hospitals incorporate harm reduction education and equipment provision.
Availability of data and materials
Substance use disorder
Syringe service program
Addiction Care Team
Ahmad F, Rossen L, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. Designed by LM Rossen, A Lipphardt, FB Ahmad, JM Keralis, and Y Chong: National Center for Health Statistics. 2021.
Suen LW, Makam AN, Snyder HR, et al. National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014–2018. J Gen Intern Med. 2021. https://doi.org/10.1007/s11606-021-07069-w.
Englander H, Weimer M, Solotaroff R, et al. Planning and Designing the Improving Addiction Care Team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12(5):339–42.
Martin M, Snyder HR, Coffa D, et al. Time to ACT: launching an Addiction Care Team (ACT) in an urban safety-net health system. BMJ Open Qual. 2021;10(1):e001111.
Priest KC, McCarty D. Role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service. J Addict Med. 2019;13(2):104–12.
Haber PS, Demirkol A, Lange K, Murnion B. Management of injecting drug users admitted to hospital. Lancet. 2009;374(9697):1284–93.
National Harm Reduction Coalition. https://harmreduction.org. Accessed 15 July 2021.
Friedman SR, De Jong W, Rossi D, et al. Harm reduction theory: Users’ culture, micro-social indigenous harm reduction, and the self-organization and outside-organizing of users’ groups. Int J Drug Policy. 2007;18(2):107–17.
Determination of Need for Syringe Services Programs. Centers for Disease Control and Prevention. https://www.cdc.gov/ssp/determination-of-need-for-ssp.html. Updated March 26, 2020. Accessed 13 May 2021.
HIV and injection drug use—vital signs—CDC. Centers for Disease Control and Prevention. 2016.
Syringe Services Programs (SSPs) Fact sheet. CDC. https://www.cdc.gov/ssp/syringe-services-programs-factsheet.html (2019). Accessed 26 March 2021.
Essential information for syringe services programs laws—August 2019. The policy surveillance program: a LawAtlas Project. https://monqcle.com/upload/5e1f53f7f5f53c5a7c8b4578/download.
Legislative Council Bureau. State of California. https://leginfo.legislature.ca.gov/faces/codes_displaySection.xhtml?lawCode=HSC§ionNum=11364.7 (2018). Accessed 31 May 2021.
Rachlis BS, Kerr T, Montaner JS, Wood E. Harm reduction in hospitals: is it time? Harm Reduct J. 2009;6(1):19.
Miskovic M, Chan Carusone S, Guta A, O’Leary B, dePrinse K, Strike C. Distribution of harm reduction kits in a specialty HIV hospital. Am J Public Health. 2018;108(10):1363–5.
Logan DE, Marlatt GA. Harm reduction therapy: a practice-friendly review of research. J Clin Psychol. 2010;66(2):201–14.
Simon R, Snow R, Wakeman S. Understanding why patients with substance use disorders leave the hospital against medical advice: a qualitative study. Subst Abus. 2019;41:519–25.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Perera, R., Stephan, L., Appa, A. et al. Meeting people where they are: implementing hospital-based substance use harm reduction. Harm Reduct J 19, 14 (2022). https://doi.org/10.1186/s12954-022-00594-9